VPT:CC - Ventripoint Announces DTC Eligibility Approval in the U.S.
(TheNewswire)
Toronto, Ontario – TheNewswire –March 21, 202 2 - Ventripoint Diagnostics Ltd. (" Ventripoint " orthe " Company "), (TSXV:VPT ) ; ( OTC:VPTDF), a biotech diagnosticcompany employing a leading ArtificialIntelligence (AI) approach known as Knowledge-Based Reconstruction(KBR™) to create applications to monitor heartdisease, is pleased to announce that theCompany’s common shares are now eligible for electronic clearing andsettlement through the Depository TrustCompany (“DTC”) in the United States (“US”).
“We are pleased to become DTCeligible. This eligibility will simplify the electronic settlement forUS- based investors and it will enhance the ability of these investorsto participate in the Company’s growth. This should also helpincrease the liquidity of our stock and expand our presence in the UScapital markets,” stated Dr. George Adams, CEO ofVentripoint.
DTC is a subsidiary of the Depository Trust & Clearing Corp. ,which manages the electronic clearing and settlement of publiclytraded companies in the US. DTC eligibility incorporates an electronicmethod of clearing securities that accelerates the receipt of stockand cash, reduces costs, and allows the stock to be traded over a muchwider selection of brokerage firms by meeting their clearing andsettlement requirements.
About Ventripoint DiagnosticsLtd.
Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary KBR technology, which is the result of a decade ofdevelopment and provides accurate volumetric cardiac measurementsequivalent to MRI. This affordable, gold-standard alternative allowscardiologists greater confidence in the management of their patients.Providing better care to patients serves as a springboard and basicstandard for all of Ventripoint's products that guide our futuredevelopments. In addition, VMS+ is versatile and can be used with allultrasound systems from any vendor supported by regulatory marketapprovals in the U.S., Europe and Canada.
For further information, pleasecontact:
John Grosso
Cory Bataan
Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.
Forward Looking Statements
This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect", "anticipate", "continue","estimate", "objective", "ongoing","may", "will", "project","should", "believe", "plans","intends'' and similar expressions are intended to identifyforward-looking information or statements. The forward-lookingstatements and information are based on certain key expectations andassumptions made by the Company. Although the Company believes thatthe expectations and assumptions on which such forward-lookingstatements and information are based are reasonable, undue relianceshould not be placed on the forward-looking statements and informationbecause the Company can give no assurance that they will prove to becorrect.
Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Company's mostrecent annual management's discussion and analysis that is availableon the Company's profile on SEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Company undertakes no obligation to update publicly orrevise any forward-looking statements or information, whether as aresult of new information, future events or otherwise, unless sorequired by applicable securities laws.
Copyright (c) 2022 TheNewswire - All rights reserved.